A novel leadless pacemaker designed for left bundle branch area pacing conferred successful pacing parameters at 1 month, but ...

The Food and Drug Administration has issued a Class I recall correction for certain Boston Scientific ACCOLADE pacemakers and cardiac resynchronization therapy pacemakers after identifying a software- ...

Highest-risk classification: FDA labeled Boston Scientific’s pacemaker recall as Class I, the most serious, due to potential ...

As of March 18, Boston Scientific has reported four deaths and 2,557 serious injuries associated with this issue, the FDA said. "The FDA has identified this recall as the most serious type. This ...

With more self-contained models potentially on their way to patients, the FDA is taking steps to remind healthcare providers of certain risks posed by leadless pacemakers, including the possibility of ...

The US Food and Drug Administration (FDA) is reminding healthcare providers about the risk of major complications if cardiac perforation occurs during leadless pacemaker implantation. Cardiac ...

Pacemaker implantation is a procedure that helps regulate irregular heart rhythms. The common conditions leading to the procedure in women differ from those in men. Following pacemaker implantation, ...

Last week, Abbott began the commercial launch of its new leadless pacemaker, which it believes is a historic development in the world of cardiac rhythm devices. Aveir DR is a better option than ...

Background: Patients over the age of 75 represent more than half the recipients of permanent pacemakers. It is not known if they have a different risk of complications than younger patients. Methods: ...